Evidence map›Paper›PMID 25989337›Full record

SynthesisInflammatory bowel diseases2015

Quality of methods reporting in animal models of colitis.

Michael Bramhall, Oscar Flórez-Vargas, Robert Stevens, Andy Brass, Sheena Cruickshank

Abstract readSystematic Review
In one paragraph

Synthesis in Inflammatory bowel diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Analysis of the Preventive Effect ofAntioxidants (Basel, Switzerland) · 2024
    Article
  5. Review
  6. Review
  7. Foods (Basel, Switzerland) · 2023
    Article
  8. International journal of molecular sciences · 2023
    Article
  9. Review
  10. Article
  11. Review
  12. Polyphenol RichAntioxidants (Basel, Switzerland) · 2022
    Article
  13. Epac-2 ameliorates spontaneous colitis in Il-10Journal of cellular and molecular medicine · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael Bramhall*Bio-Health Informatics Group, School of Computer Science, University of Manchester, Manchester, United Kingdom; and †Manchester Immunology Group, Faculty of Life Science, University of Manchester, Manchester, United Kingdom.
Oscar Flórez-Vargas
Robert Stevens
Andy Brass
Sheena Cruickshank

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent understanding of the onset of inflammatory bowel diseases relies heavily on data derived from animal models of colitis. However, the omission of information concerning the method used makes the interpretation of studies difficult or impossible. We assessed the current quality of methods reporting in 4 animal models of colitis that are used to inform clinical research into inflammatory bowel disease: dextran sulfate sodium, interleukin-10, CD45RB T cell transfer, and 2,4,6-trinitrobenzene sulfonic acid (TNBS).

methodsWe performed a systematic review based on PRISMA guidelines, using a PubMed search (2000-2014) to obtain publications that used a microarray to describe gene expression in colitic tissue. Methods reporting quality was scored against a checklist of essential and desirable criteria.

resultsFifty-eight articles were identified and included in this review (29 dextran sulfate sodium, 15 interleukin-10, 5 T cell transfer, and 16 TNBS; some articles use more than 1 colitis model). A mean of 81.7% (SD = ±7.038) of criteria were reported across all models. Only 1 of the 58 articles reported all essential criteria on our checklist. Animal age, gender, housing conditions, and mortality/morbidity were all poorly reported.

conclusionsFailure to include all essential criteria is a cause for concern; this failure can have large impact on the quality and replicability of published colitis experiments. We recommend adoption of our checklist as a requirement for publication to improve the quality, comparability, and standardization of colitis studies and will make interpretation and translation of data to human disease more reliable.

Indexed as

Disease Models, AnimalAnimalsChecklistColitisDextran SulfateHumansInflammatory Bowel DiseasesInterleukin-10Leukocyte Common AntigensResearch DesignTrinitrobenzenesulfonic AcidDextran SulfateInterleukin-10Leukocyte Common AntigensTrinitrobenzenesulfonic Acid

Identifiers

PMID25989337
PMCPMC4450905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.